BioSpace News Archive

BioMidwest

Neogen® Wins Best Innovative Luminol-Based Substrate Award

Neogen® Corporation announced that its K-Blue® Luminescent ONE has won the 2023 Best Innovative Luminol-Based Substrate award at the International Life Sciences Awards 2023.

August 30, 2023
·
2 min read
Genetown

Editas Medicine Announces Upcoming September 2023 Investor Events

Editas Medicine, Inc., a clinical-stage genome editing company, announced that management will participate in the following upcoming investor conferences.

August 30, 2023
·
1 min read
Drug Development

XBiotech Announces Enrollment Completion of Phase II, Placebo Controlled, Multicenter Study for Natrunix in Pancreatic Cancer

XBiotech Inc. announced today completion of enrollment of the Phase II portion of its 1-BETTER study—a Phase I/II randomized, double-blind, placebo-controlled clinical study for Natrunix in combination with chemotherapy for treating pancreatic cancer.

August 30, 2023
·
2 min read
Drug Development

Journal of Cosmetic Dermatology Publishes Data Demonstrating Patient Satisfaction with Natural-Looking Outcomes Following Treatment with OnabotulinumtoxinA (BOTOX® Cosmetic)

Allergan Aesthetics, an AbbVie company (NYSE: ABBV), today announced the Journal of Cosmetic Dermatology published results from a year-long, post-hoc analysis of patient-reported outcomes (PROs) from two Phase 3 clinical studies evaluating the impact of onabotulinumtoxinA (BOTOX® Cosmetic) on upper facial lines (UFLs) in adults new to toxin treatment.

August 30, 2023
·
11 min read
Press Releases

LOTTE BIOLOGICS Holds ‘ESG Declaration Ceremony’

August 30, 2023
·
4 min read